Evaluating The Efficacy And Safety Of Transitioning Patients From Natalizumab To Ocrelizumab (Octave)K. Smoot,T. Gervasi-Follmar,C. Chen,P. Repovic, H. -J. Zhang,C. Moreno,S. CohanNEUROLOGY(2020)引用 4|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要